ATP Life Science Ventures L.P. 13D and 13G filings for Stoke Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-06-28 8:54 pm Sale | 2021-06-21 | 13D | Stoke Therapeutics, Inc. STOK | ATP Life Science Ventures L.P. | 1,912,256 5.200% | -15,293,789 (-88.89%) | Filing |
| 2020-11-27 4:58 pm Purchase | 2020-11-20 | 13D | Stoke Therapeutics, Inc. STOK | ATP Life Science Ventures L.P. | 17,206,045 47.500% | 419,332 (+2.50%) | Filing |